Evidence map›Paper›PMID 39564118›Full record

ArticleFrontiers in pharmacology2024

The effect of cognitive emotion regulation on direct-acting antivirals adherence in patients with hepatitis C.

Adina Turcu-Stiolica, Irina Paula Doica, Bogdan Silviu Ungureanu, Mihaela-Simona Subtirelu, Dan Nicolae Florescu, Razvan-Aurelian Turcu-Stiolica, Ion Rogoveanu, Dan-Ionut Gheonea

Abstract read
In one paragraph

Article in Frontiers in pharmacology, 2024. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 2 papers.

0numbers the graph read from it
0cells of the map it votes in
2citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

2 citing papers in PubMed.

  1. Review
  2. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

8 authors.

Adina Turcu-Stiolica *Pharmacoeconomics Department, University of Medicine and Pharmacy of Craiova, Craiova, Romania.
Irina Paula Doica *Gastroenterology Department, University of Medicine and Pharmacy of Craiova, Craiova, Romania.
Bogdan Silviu Ungureanu *Gastroenterology Department, University of Medicine and Pharmacy of Craiova, Craiova, Romania.
Mihaela-Simona Subtirelu *Pharmacoeconomics Department, University of Medicine and Pharmacy of Craiova, Craiova, Romania.
Dan Nicolae FlorescuGastroenterology Department, University of Medicine and Pharmacy of Craiova, Craiova, Romania.
Razvan-Aurelian Turcu-StiolicaTrueman Consulting, Craiova, Romania.
Ion RogoveanuGastroenterology Department, University of Medicine and Pharmacy of Craiova, Craiova, Romania.
Dan-Ionut GheoneaGastroenterology Department, University of Medicine and Pharmacy of Craiova, Craiova, Romania.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Introduction: Adherence to direct-acting antivirals (DAAs) could be a predictor of chronic viral hepatitis C (HCV) therapeutic failure. We examined the perceptions of patients receiving DAAs to determine how cognitive factors influence their decision to maintain adherence. Also, we explored the threshold of DAAs adherence for obtaining sustained virologic response (SVR) among patients with HCV, in order to better implement a strategy that improves the DAAs adherence in the future clinical practice. Methods: A single-arm prospective study was performed. Patients with HCV that started and completed DAAs treatment in the County Hospital of Craiova, Dolj, Romania, were enrolled. Patients' medication adherence was assessed using the HCV-AD10 questionnaire, and the cognitive emotion regulation was measured with CERQ questionnaire (five positive/adaptive cognitive emotion-regulation domains and four negative/maladaptive domains). Spearman correlation analysis was conducted to explore the relationships between adherence and different factors. ROC-curves were used to evaluate the adherence threshold to achieve SVR. A linear regression model was performed to analyze the primary outcome (DAAs adherence) to be the target variable based on given independent variables (age, treatment duration, severity of HCV, the nine adaptive and maladaptive strategies). Results: 368 patients (mean age: 61 years) with HCV diagnosed 4.05 ± 6.38 (average) years ago were enrolled. Mean (±SD) adherence via HCV-AD10 was 91.51 ± 8.34, and the proportion of the participants achieving SVR was 96%. Patients with an adherence less than 84% (5 patients, 1.36%) was considered nonadherent and they have a high probability of not achieving response (sensitivity and specificity of 83% and 80%, respectively). We obtained significantly higher values of three adaptive strategies between adherent and nonadherent patients following DAAs treatment: in positive refocusing ( Discussion: The interplay between the three adaptive strategies of the cognitive emotion regulation and the enhancement of DAAs adherence contributes to a more holistic comprehension of patient behavior in the context of HCV treatment. Increasing refocusing and planning using goal setting and assisting patients in establishing specific, achievable goals can be crucial strategies for clinicians aiming to improve adherence among their patients.

Indexed as

adherencecognitive emotion regulationdirect-acting antiviral (DAA)hepatitis Cself-reported questionnaire

Identifiers

PMID39564118
PMCPMC11574304

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.